Troxsal is indicated for topical symptomatic treatment of: chronic venous insufficiency; varicose vein disease and hemorrhoids; superficial thrombophlebitis, acute phlebitis and post-thrombophlebitic syndrome; post-phlebosclerotic pain.
Product information
| Active substance | INN: Troxerutinum |
|---|---|
| Therapeutic Class | CAPILLARY STABILIZING AGENTS (BIOFLAVONOIDS) |
| Therapeutic indications | Troxsal is indicated for the topical symptomatic treatment of chronic venous insufficiency, varicose veins and hemorrhoids, superficial thrombophlebitis, acute phlebitis, post-thrombophlebitic syndrome and post-phlebosclerotic pain. |
| Pack size | Box containing 1 aluminum tube of 45 g gel |
| Method and route of administration | Apply a thin layer of gel to the affected area and gently massage until absorbed. DO NOT apply Troxsal to areas with lesions, eczema or open sores of the skin, mucous membranes, particularly the eyes! If symptoms do not improve within 5 days or worsen, consult your doctor. |
| Legal status | OTC |
| Shelf life | 3 years in original packaging 6 weeks after the first opening. |
| Marketing status | Currently marketed |
Package Leaflet (PL) - Romanian
Package Leaflet (PL) - English